CTD // Fund

BioVeda China Fund

VC firm funding companies in China and the US

← Fund directory

BioVeda China Fund

china

BioVeda China Fund is an institutional investor (Conventional VCs) founded in 2005 and headquartered in Huangpu, China. BioVeda China Fund (BVCF) is a venture capital firm. Geographies of interest include China and the US. Invests in Healthcare sectors operating in areas like HealthTech, Medical Devices, Diagnostics and Healthcare services. Notable portfolio companies include MicuRx Pharmaceuticals, Clarus Therapeutics, Quark Pharmaceuticals, Cathay Biotech. The firm has AUM worth $400 m. Notable portfolio companies: MicuRx Pharmaceuticals, Clarus Therapeutics, Quark Pharmaceuticals, Cathay Biotech.

Stage: Not disclosed
HQ: Huangpu, china
Founded: 2005
Website: https://bvcf.com
LinkedIn: https://linkedin.com/company/%E7%99%BE%E5%A5%A5%E8%B4%A2%E5%AF%8C

Institutional InvestorHealthcareHealthTechBiotechBiopharma

Related startups

ScreenPoint

Developer of artificial intelligence software for analyzing breast imaging mammograms. This technology integrates with existing medical imaging hardware to…

HealthTech · Nijmegen, Netherlands

Liom

Platform offering non invasive glucose monitoring solutions. The company's glucose monitoring technology, seamlessly integrated with health metrics, to…

HealthTech · Pfaffikon, Switzerland

RISA Labs

Provider of solutions for automating clinical operation. Platform leveraging artificial intelligence to streamline healthcare processes, particularly in the…

HealthTech · Cambridge, United States

📊 Valuation calculator for deal screening — free tool using revenue multiples by sector and round.

⚠️ What makes founders get rejected →

Preparing to pitch BioVeda China Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →